title: Effects of different five-day progesterone-based synchronization protocols on the estrous response and follicular/luteal dynamics in dairy cows.
abstract: This study compared the responses shown by lactating dairy cows to four different P4-based protocols for AI at estrus. Cows with no estrous signs 96 h after progesterone intravaginal device (PRID) removal were subjected to fixed-time AI (FTAI), and their data were also included in the study. In Experiment I, follicular/luteal and endometrial dynamics were assessed every 12 h from the beginning of treatment until AI. The estrous response was examined in Experiment II, and fertility was assessed in both experiments. The protocols consisted of a PRID fitted for five days, along with the administration of different combinations of gonadotropin releasing hormone (GnRH), equine chorionic gonadotropin and a single or double dose (24 h apart) of prostaglandin F2α. In Experiment I (40 cows), animals receiving GnRH at the start of treatment showed a significantly higher ovulation rate during the PRID insertion period while estrus was delayed. In Experiment II (351 cows), according to the odds ratios, cows showing luteal activity at the time of treatment were less likely to show estrus than cows with no signs of luteal activity. Treatment affected the estrous response and the interval from PRID removal to estrus but did not affect conception rates 28-34 days post AI. Primiparous cows displayed a better estrous response than multiparous cows. Our findings reveal acceptable results of 5-day P4-based protocols for AI at estrus in high-producing dairy cows. Time from treatment to estrus emerged as a good guide for FTAI after a 5-day P4-based synchronization protocol.
authors.affiliation: Agrotecnio Centre, University of Lleida, Lleida 25198, Spain.
authors.forename: Fernando
authors.initials: F
authors.lastname: López-Gatius
authors.forename: Irene
authors.initials: I
authors.lastname: López-Helguera
authors.forename: Fabio
authors.initials: F
authors.lastname: De Rensis
authors.forename: Irina
authors.initials: I
authors.lastname: Garcia-Ispierto
mesh_terms: D000282:Administration, Intravaginal; D000818:Animals; D002417:Cattle; D006063:Chorionic Gonadotropin / Q000008:administration & dosage / Q000494:pharmacology; D003433:Crosses, Genetic; D003612:Dairying; D015237:Dinoprost / Q000008:administration & dosage* / Q000494:pharmacology; D004334:Drug Administration Schedule / Q000662:veterinary; D004343:Drug Implants; D004717:Endometrium / Q000187:drug effects; D004971:Estrus / Q000097:blood / Q000187:drug effects*; D004973:Estrus Synchronization / Q000097:blood / Q000379:methods*; D005260:Female; D005298:Fertility / Q000187:drug effects; D005300:Fertility Agents, Female / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage* / Q000494:pharmacology; D007273:Injections, Intramuscular; D007315:Insemination, Artificial / Q000662:veterinary; D007774:Lactation / Q000187:drug effects; D010060:Ovulation / Q000097:blood / Q000187:drug effects*; D011247:Pregnancy; D011374:Progesterone / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D011897:Random Allocation; D013030:Spain
chemical_list: D006063:Chorionic Gonadotropin; D004343:Drug Implants; D005300:Fertility Agents, Female; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone; D015237:Dinoprost